These final results, together with a preceding report demonstrating that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 help the idea of targeting ACKR3 as a novel technique to modulate the opioid program, which could open new therapeutic avenues for opioid-related Diseases. So, just before investing in https://lauram258plg6.blogars.com/profile